Oral Anticoagulants Market Players, Size, Share, Opportunities, Trends and Forecast to 2030
Oral Anticoagulants Market Anticoagulant is a drug, when added to blood, prevents it from clotting. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood. Such drugs are often used to prevent the formation of blood clots (thrombi) in the veins or arteries or the enlargement of a clot that is circulating in the bloodstream. The Oral Anticoagulants Market is expected to reach 37.96 billion by 2030 at 8.90% CAGR during the forecast period 2023-2030. Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global oral anticoagulants market in recent years. However, the high cost is likely to restrain market growth over the forecast period. Major Key Players: Market Research Future (MRFR) recognizes the Oral Anticoagulants Market Players are AstraZeneca, Plc (UK), Pfizer (US), Boehringer Ingelheim GmbH (Germany...